Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

R. Constance Wiener, Patricia A. Findley, Chan Shen, Nilanjana Dwibedi, Usha Sambamoorthi

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Human papillomavirus (HPV) vaccination acceptance is hampered by fears and conflicting attitudes about the need for and safety of vaccine. There are also ethical dilemmas associated with vaccinating adolescents for a sexually transmitted disease despite future cancer risk. The purpose of this research was to determine HPV vaccination acceptance/hesitancy among young adults. Behavioral Risk Factor Surveillance System 2015 data were used. During 2015, 83.1% of adults ages 25–29 years did not receive any HPV vaccination; the UOR was 3.47; 95% CI = 2.11, 5.70) compared to adults 18–24 years. There is a need to accelerate public health messaging/campaigns to increase HPV vaccination rates.

Original languageEnglish (US)
Pages (from-to)5119-5122
Number of pages4
Issue number33
StatePublished - Jul 14 2020

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • General Immunology and Microbiology
  • General Veterinary
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015'. Together they form a unique fingerprint.

Cite this